$FIVE

Goldman Sachs reiterates Buy on Five Below stock, cites sourcing shift

Goldman Sachs reiterated a Buy rating and $306 price target on Five Below (FIVE), citing operational changes and sourcing shifts. The stock trades at $222.38, with a P/E of 20.28 and PEG of 0.16. Five Below reported 25.6% revenue growth over the last year and a 14.1% increase in comparable sales in Q2, exceeding guidance and consensus estimates. Multiple analysts raised their price targets following the strong results.

Original reporting
Published Sep 25, 2026, 10:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 12:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FIVE
Bullish
medium confidence
Mentioned
$FIVE
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FIVEBullishLow
01

Why it matters

Analyst upgrades reinforce existing bullish sentiment but add little new actionable insight.

02

Market read

Modest relevance for traders focused on discount retail stocks.

03

What to watch

Potential supply‑chain risks from increased India sourcing.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

Article recaps Five Below's recent earnings and analyst actions, originally released earlier in the month.

Company-level read

Ticker impact

$FIVEBullishMedium confidence
Context

Goldman Sachs reiterates Buy rating and $306 price target, citing operational changes and recent strong Q2 results.

Expected impact

Potential modest price increase toward target.

Evidence & confidence

Buy rating and higher target reflect confidence in growth initiatives.

Market effects

Highlights discount retailer resilience, may benefit peers.

U.S. retail sector perception modestly improved.

Limited to U.S. consumer discretionary space.

Counterpoint

Price target may be overly optimistic given valuation.

Key entities

  • Goldman Sachs

    Reiterated Buy rating and raised price target.

Related articles

$CROXMed

Crocs Sues Five Below Over Alleged Knockoff Clogs and Charms

Crocs sued Five Below for allegedly infringing on its patents and trademarks with the sale of its Juniors Charm Clog. The lawsuit, filed in Colorado, claims Five Below's clogs and charms mimic Crocs' designs, misleading consumers. Crocs seeks damages, a permanent injunction, and destruction of infringing inventory. Five Below's clogs retail for $7, while Crocs' Kids Classic Clog sells for $39.99.

$CROXMed

Crocs and Five Below are in a legal fight over a $7 shoe

Crocs is suing Five Below, alleging that its clogs and charms infringe on Crocs' trademarks and patents. The lawsuit seeks damages, a halt to sales, and destruction of inventory. Five Below reported strong financial results, with net sales up 27% and net income over $344 million. Crocs generates over $4 billion in annual sales.

$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs has sued Five Below, alleging trademark and patent infringement by selling clogs and accessories resembling Crocs' products. The lawsuit, filed in Colorado, seeks damages and a permanent injunction. Five Below's net sales increased over 27% year-over-year, with net income of $344 million as of August, according to its earnings report.

$FIVEMed

Five Below Maps Growth With Store Revamp, Customer Focus and $600M Buyback

Five Below (FIVE) reported five consecutive quarters of double-digit comparable sales growth, driven by new merchandise and marketing. The company plans to open 7% to 9% more stores annually, with a U.S. store opportunity of over 3,500 locations. Five Below announced a $600M share repurchase program, prioritizing growth investments. Management expects modest capital expenditure for store format changes and sees strong consumer demand across demographics and categories, particularly in toys.